Acute megakaryoblastic leukemia
Information
- Disease name
- Acute megakaryoblastic leukemia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00392353 | Active, not recruiting | Phase 1/Phase 2 | Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia | November 22, 2006 | September 30, 2024 |
| NCT01823198 | Completed | Phase 1/Phase 2 | Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies | June 11, 2013 | May 10, 2022 |
| NCT04083170 | Terminated | Phase 2 | Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers | October 6, 2022 | November 30, 2022 |
| NCT02530619 | Unknown status | N/A | Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia | October 9, 2015 | May 2022 |
- OrphaNumber from OrphaNet (Orphanet)
- 518